Guest guest Posted January 30, 2010 Report Share Posted January 30, 2010 > > [MedWatch logo] > [MedWatch - The FDA Safety Information and Adverse Event Reporting Program] >> > > Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension > > > Audience - HIV/AIDS, Infectious Disease healthcare professionals > > FDA notified healthcare professionals and patients about a rare, but serious, complication in the liver known as non-cirrhotic portal hypertension in patients using Videx or Videx EC (didanosine), a medication used to treat human immunodeficiency virus (HIV) infection. FDA became aware of cases of non-cirrhotic portal hypertension through adverse event reports submitted to FDA's Adverse Event Reporting System. Based on the number of well-documented cases and exclusion of other > causes of portal hypertension such as alcohol-related cirrhosis or hepatitis C, FDA concludes there is an association between use of didanosine and development of non-cirrhotic portal hypertension. Because of the potential severity of portal hypertension, including death from hemorrhaging esophageal varices, FDA has revised the Warning and Precautions section of the didanosine drug label to assure safe use of the medication. FDA believes the clinical benefits of didanosine for certain patients > with HIV continue to outweigh its potential risks. The decision to use this drug, however, must be made on an individual basis between the treating physician and the patient. > > > Read the complete MedWatch 2010 Safety summary including a link to the Drug Safety Communication, at: > > > http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedical\ Products/ucm199343.htm > > > > > > ________________________________ > > > Manage your FDA Subscriptions: > > > * Update your preferences or unsubscribe > > * Questions about this service? support@... > > * Other inquiries? webmail@... > > > > > [Fight Flu with Facts! Visit flu.gov. Call 800-232-4636. Text FLU to 87000.] > > > > > > > > GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) > · 5600 Fishers Lane > > · Rockville MD 20857 > · 800-439-1420 > > > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.